Cassava Sciences, Inc.
SAVA
$2.05
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.40M | -27.60M | -27.94M | 6.16M | 25.04M |
| Total Depreciation and Amortization | 220.00K | 260.00K | 259.00K | 302.00K | 311.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.23M | 5.74M | 5.61M | -62.54M | -40.71M |
| Change in Net Operating Assets | 6.62M | -39.67M | 3.78M | 37.84M | -3.78M |
| Cash from Operations | -11.34M | -61.27M | -18.30M | -18.24M | -19.13M |
| Capital Expenditure | -- | -57.00K | -17.00K | -29.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -57.00K | -17.00K | -29.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.00K | 918.00K | 0.00 | 101.39M | 22.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.00K | 918.00K | 0.00 | 101.39M | 22.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.25M | -60.40M | -18.31M | 83.12M | 3.03M |